Toxicology Flashcards
Potential toxicities of new drugs are assessed after..
the pharmacological efficacy of the drug is proven
Requirement of the FDA to assess potential toxicities is due to..
how drugs can cause adverse effects in man
What is involved in tox testing?
acute tests that provide the basis for further study and chronic tox performed under GLP to determine long-term tox potential
Instance of tox of a drug not being found before being on market
1956-60 thalidomide was prescribed to pregnant women for morning sickness and resulted in malformed children
Thalidomide was not tested on the most sensitive species
In silico approaches
developed to characterise and predict toxic outcomes
methods already used for regulatory purposes, will be more prominent in future
Why are in silico tests important
large scale of chemicals studied, endpoints and pathways, exposure etc. all analysed and conditions considered simultaneously
(Kavlock et al, 2008)
Software for in silico
DEREK used to compare test drugs structures to highlight any tox
Single dose acute studies
tox that results from a single dose of compound
What does single dose acute studies give..
an early warning whether a drug is highly toxic
What can single dose acute studies establish
a non-lethal dose range and aids the choice of doses for repeat dose studies
provide information on target organs and limiting tox due to pharmacological effects
Single dose acute studies is carried out on..
2 different species
one rodent
one non-rodent
Investigational product in single dose studies is administered..
at different dose levels and observed for 14 days
Single does studies allow..
LD50 to be determined, 50% lethal dose
Stage 2 of acute dose studies
repeat of stage 1 in small groups (3-5 animals per sex)
span estimated NTEL
Observations made throughout and blood samples taken .. example
Irwin’s test for nervous system
Parasuraman 2011 example
Used Draize test
acute tox test to measure harmfulness of chemicals on rabbits and guinea pigs
(0.5g of substance and observe for 24 days)
Dermal and ophthalmic preparations tested
Look for redness, swelling, discharge etc
Dose ranging studies
Tox of repeated doses at dose levels ranging from ED50 to max non-lethal dose
Dose ranging studies help establish
Max tolerated dose (MTD)
MTD
highest dose that can be given to animals for the duration of the test that doesnt produce overt tox
Dose ranging studies are carried out in..
rodent and non-rodent
they are sacrificed and post mortem and histological analysis of major organs and tissues taken
One month repeated dose can be used to..
support clinical trials
One month repeated dose allow
administration of single or multiple doses in man for up to 6 months
One month repeated dose aid..
selection of doses for long-term investigations and help to identify possible target organs and tissues
Use what for one month repeated dose
proposed administration route
minimum of 3 dose levels
dosed for 29 days
Survivors sacrificed day 30
Detailed monitoring of what in one month repeated dose studies
food/ water intake body weight general behaviour blood/ urine chemistry haematology
Important feature of one month repeated dose studies
recovery group for both species
can be observed for up today 56
usually have 2nd satellite group of dosed rates so toxicokinetics can be assessed in this species
Greaves et al 2004
Showed if tox studies are shorter than 1 month, risk of certain organ tox being overlooked
single studies have capacity to detect many of most important tox
Six month repeat dose studies (chronic)
necessary for long-term clinical trials (Phase II and III) and for marketing approval
Six month repeat dose studies are similar to..
30-day study
treatments and free recovery period
assess reversibility of tox effects after 3 months
Acute short and long term studies are standard as..
performed for majority of candidate drugs
Specialist test later in development: oncogenicity and reproductive tox
Oncogenicity studies required when ..
compound is intended for long-term use in man (>6 months)
if drug has long half-life
where there is concern because of the compound pharmacologies or toxic effects
if mutagenicity tests are positive